Cardinal health reports third quarter fiscal 2022 results

Revenue increased 14% to $44.8 billion gaap 1 operating loss was $97 million due to a non-cash, pre-tax goodwill impairment of $474 million in the medical segment; gaap diluted loss per share was $5.05, primarily due to this impairment, net of tax effects non-gaap operating earnings decreased 21% to $545 million, primarily due to a decline in medical segment profit; non-gaap diluted eps decreased 5% to $1.45 finalized the previously announced national opioid settlement agreement company updates fy22 guidance dublin, ohio , may 5, 2022 /prnewswire/ -- cardinal health (nyse: cah) today reported third quarter fiscal year 2022 revenues of $44.8 billion, an increase of 14% from the third quarter of last year. third quarter gaap operating loss was $97 million, due to a non-cash, pre-tax goodwill impairment of $474 million in the medical segment.
CAH Ratings Summary
CAH Quant Ranking